tm logo
Trademark Search
CUREVO

View On IC.GC.CA

CUREVO
REGISTERED

on 03 Mar 2020

Last Applicant/ Owned by

CUREVO INC.

21540 30th Dr. SE#260Bothell, WA 98021

US

Serial Number

1859725 filed on 27th Sep 2017

Registration Number

TMA1074118 registered on 03rd Mar 2020

Registration expiry Date

03rd Mar 2030

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

CUREVO

Trademark usage description

blood plasma-derivatives, namely albumins for use as a therapeutic agent in surgery and blood loss, albumins for use in the manufacture of human vacci Read More

Classification Information

Class [001]
Blood plasma-derivatives, namely albumins for use as a therapeutic agent in surgery and blood loss, albumins for use in the manufacture of human vaccines; recombinant proteins, namely enzymes and blood clotting factors, for use in the medical and pharmaceutical industry, namely, enzymes for use in the manufacture of nutraceuticals.

Classification kind code

11

Class [005]
Pharmaceuticals for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Hunter Syndrome, Hemophilia A, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, influenza, and chronic pain, kidney diseases, ocular or intraocular surgery; human vaccines, influenza vaccines and vaccine components; therapeutic antibodies for the prevention and treatment of Hepatitis B, influenza.

Classification kind code

11

Class [035]
Wholesale distributorships of pharmaceutical products for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Hunter Syndrome, Hemophilia A, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, influenza, and chronic pain, kidney diseases, ocular or intraocular surgery; retail store services for pharmaceutical products for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Hunter Syndrome, Hemophilia A, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, influenza, and chronic pain, kidney diseases, ocular or intraocular surgery; business agency services, namely, export and import agencies in the field of pharmaceutical products; wholesaling, distributorships in the field of pharmaceutical products, and retailing of pharmaceutical products for the prevention and treatment of cancer, cerebrovascular thrombosis, myocardial infarctions, peripheral artery occlusions, pulmonary embolisms, thrombophlebitis, Japanese Encephalitis, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Hunter Syndrome, Hemophilia A, osteoarthritis, arthritis deformans, periarthritis humeroscapularis, tendinitis, peritendinitis, humeral epicondylitis, idiopathic thrombocytopenic purpura, Guillain-barre syndrome, Kawasaki syndrome, Clostridium tetani, influenza, and chronic pain, kidney diseases, ocular or intraocular surgery; procurement services for others, namely, purchasing pharmaceutical products for other businesses.

Classification kind code

11

Class [036]
Financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of pharmaceutical products ; financial intermediary services, namely, facilitating the channeling of funds between lenders and borrowers by connecting those with a financial surplus with those having a financial deficit in the field of medical machines and apparatus.

Classification kind code

11

Class [042]
Research and development in the field of pharmaceuticals, vaccines, plasma-derivatives, recombinant proteins and therapeutic antibodies; laboratory and scientific research in the field of pharmaceuticals, vaccines, plasma-derivatives, recombinant proteins and therapeutic antibodies.

Classification kind code

11

Mark Details

Serial Number

1859725

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 04th Dec 2019		Advertised
Submitted for opposition 27
on 14th Nov 2019		Approval Notice Sent
Submitted for opposition 26
on 14th Nov 2019		Approved
Submitted for opposition 15
on 07th Oct 2019		Correspondence Created
Submitted for opposition 15
on 08th Mar 2019		Correspondence Created
Submitted for opposition 22
on 02th Oct 2018		Search Recorded
Submitted for opposition 20
on 02th Oct 2018		Examiner's First Report
Submitted for opposition 31
on 29th Sep 2017		Formalized
Submitted for opposition 30
on 27th Sep 2017		Filed
Submitted for opposition 1
on 27th Sep 2017		Created